Dosing & Uses
Hypoparathyroidism
Pending FDA approval for hypoparathyroidism
Next:
Pharmacology
Mechanism of Action
Prodrug of parathyroid hormone (PTH) 1-34; it is bound to a linker and pegylated carrier that prevents binding to the PTH1R to extend the drug’s half-life
Previous
Next:
Images
No images available for this drug.
Previous
Next:
Medscape prescription drug monographs are based on FDA-approved labeling information, unless otherwise noted, combined with additional data derived from primary medical literature.
